Clinical TrialID 5218
Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris
NCT00361322
Acne Vulgaris
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5218
- Evidence Id
- 5218
- Core Evidence Id
- 5218
- Source Clinical Trial Id
- 5200
- Herb2 Clinical Trial Id
- HBCT005200
- Nct Id
- NCT00361322
- Title
- Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris
- Status
- Completed
- Phase
- Phase 1|Phase 2
- Study Result
- No
- Study Condition
- Acne Vulgaris
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
- Intervention
- DRUG: clindamycin phosphate|DRUG: salicylic acid
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult
- Enrollment
- 40
- Outcome Measure
- Lesions count at the baseline (week 0)|Lesions count at the end of study (week 8)
- Sponsor Collaborator
- Hadassah Medical Organization
- Funded By
- OTHER
- Location
- Hadassah Medical Organization, Jerusalem, 91120, Israel
- Other Id
- CLSA-HMO-CTIL
- Start Date
- 2005-04
- Primary Completion Date
- Completion Date
- 2006-01
- First Posted
- 2006-08-08
- Results First Posted
- Last Update Posted
- 2006-08-08
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00361322
- Title Cn
- Title En
- Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris
- Bilingual Status
- semi_complete